The rise in prevalence of chronic diseases coupled with the rapidly ageing population drives the growth of the market. Moreover, increased awareness and technological advancements in medical implants also contributes toward the growth of the market. However, high implantation cost and lack of trained professionals in the medical surgeries sector are the major barriers for the growth of the market. Conversely, the surge in number of the reimbursement policies is expected to offer lucrative opportunities for market expansion during the forecast period.
The implantable medical devices market is segmented on the basis of product and region. By product, the market is categorized into orthopedic implants, dental implants, breast implants, cardiovascular implants, intraocular lenses and other implants. The orthopedic implants are further classified as spinal implants and reconstructive joint replacements. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Benefits For Stakeholders
- This report provides a detailed - Quantitative analysis of the current market trends and future estimations from 2020 to 2030, which assists to identify the prevailing market opportunities.
- An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders to formulate region-specific plans.
- A comprehensive analysis of the factors that drive and restrain the growth of the implantable medical devices market is provided.
- An extensive analysis of various regions provides insights that allow companies to strategically plan their business moves.
- Key market players and their strategies have been analyzed to understand the competitive outlook of the market.
Key Market Segments
BY PRODUCT
- Breast Implants
- Other Implants
- Orthopedic Implants
- Cardiovascular Implants
- Intraocular Lens
- Dental Implants
BY REGION
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- Abbott Laboratories
- Biotronik SE and Co. KG
- Boston Scientific Corporation
- C. R. Bard, Inc.
- Cardinal Health, Inc.
- CONMED Corporation
- Globus Medical, Inc.
- Integra LifeSciences Holdings Corporation
- Johnson and Johnson
- LivaNova PLC
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
Executive Summary
According to this report titled, 'Implantable Medical Devices Market,' the implantable medical devices market was valued at $91,868.94 million in 2020, and is estimated to reach $179.0 Billion by 2030, growing at a CAGR of 7.2% from 2021 to 2030.An implant is a medical device, which is used to replace or support any damaged body organs, improve the functioning of body organs, or treat defects in normal body functions. These can be surgically implanted either permanently or temporarily in the human body, and can be removed when dispensable. These implantable devices comprise bones, tissues, skin, ceramics, metals, plastics, and other natural materials. Medical implants are used to replace a missing biological structure, support a damaged biological structure, or enhance an existing biological structure.
The major factors that drive the implantable medical devices market growth are increase in geriatric population, rapid technological advancements, rise in incidence of chronic diseases, surge in adoption of advanced implantable medical devices, and growth in awareness about the benefits & availability of these devices. Moreover, increase in the awareness for implants in emerging economies also contributes toward the growth of the implantable medical devices market trends. However, the high cost of implantable medical devices and limited insurance coverage are expected to restrain the market growth during the forecast period. Conversely, ongoing R&D activities in the field of implantable medical devices offer lucrative growth opportunities for the market.
Coronavirus (COVID-19) was discovered in late December, 2019, in Hubei province of Wuhan city in China. The disease is caused by a virus, namely, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is transmitted among humans. Amidst the initial outbreak of COVID-19, the reduced hospital admissions of the patients to undergo implant surgery were observed. Various regions reported the reduction in patient admission in the hospital indicating that many patients with moderate and severe disabilities were avoiding hospital visits. Overall, the IMPACT OF COVID-19 on the implantable medical devices industry was recorded to be fairly negative. This was attributed to decrease in the demand for the implant surgeries. Moreover, the market players have reduced the investment in raw materials and resources owing to decline in number of hospital admission of the patients to undergo the implant surgeries.
-The implantable medical devices market is segmented on the basis of product and region. By product, the implantable medical devices market size is categorized into orthopedic implants, dental implants, breast implants, cardiovascular implants, intraocular lenses, and other implants. The orthopedic implants are further classified as spinal implants and reconstructive joint replacements. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
-On the basis of product, the global implantable medical devices market is classified into orthopedic implants, dental implants, breast implants, cardiovascular implants, intraocular lenses, and other implants. The other implants segment was the major implantable medical devices market size to the global market in 2020, and is anticipated to remain dominant during the forecast period due to technological advancements in the implantable medical devices, increase in adoption of implantable medical devices, rise in incidence rate of chronic cardiovascular diseases, and surge in number of advanced and effective product launches.
-North America accounted for major share of the global implantable medical devices market share in 2020, and is expected to remain dominant throughout the forecast period. This is attributed to increase in incidences of chronic diseases, surge in demand for implantable medical devices, availability of advanced healthcare facilities with trained medical professionals, rise in number of R&D activities coupled with large presence of key players, and surge in investment made by governments in the healthcare system. However, Asia-Pacific is expected to experience the highest growth rate during the forecast period. Moreover, Japan and China are expected to grow at high CAGR in Asia-Pacific implantable medical devices market majorly due to improvement in healthcare infrastructure, rise in number of hospitals equipped with advanced instruments, development of the R&D sector, upsurge in healthcare reforms, and technological advancements in the field of implants.
Companies Mentioned
- Abbott Laboratories
- Biotronik SE and Co. KG
- Boston Scientific Corporation
- C. R. Bard, Inc.
- Cardinal Health, Inc.
- CONMED Corporation
- Globus Medical, Inc.
- Integra LifeSciences Holdings Corporation
- Johnson and Johnson
- LivaNova PLC
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 225 |
Published | March 2022 |
Forecast Period | 2020 - 2030 |
Estimated Market Value ( USD | $ 91868.94 million |
Forecasted Market Value ( USD | $ 179032.75 million |
Compound Annual Growth Rate | 6.9% |
Regions Covered | Global |
No. of Companies Mentioned | 10 |